Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies

Prognosis of patients with cystic fibrosis (CF) varies extensively despite recent advances in targeted therapies that improve CF transmembrane conductance regulator (CFTR) function. Despite being a multi-organ disease, extensive lung tissue destruction remains the major cause of morbidity and mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Allan, Katelin M., Farrow, Nigel, Donnelley, Martin, Jaffe, Adam, Waters, Shafagh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007963/
https://www.ncbi.nlm.nih.gov/pubmed/33796025
http://dx.doi.org/10.3389/fphar.2021.639475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007963/
https://www.ncbi.nlm.nih.gov/pubmed/33796025
http://dx.doi.org/10.3389/fphar.2021.639475

Ejemplares similares